Ms. Grace E. Saunders, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 9 Holyoke Ln, Willingboro, NJ 08046 Phone: 609-877-7810 |
George Tucker, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 218a Sunset Rd, Willingboro, NJ 08046 Phone: 609-835-2901 |
Lauren Calise, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 218a Sunset Rd, Willingboro, NJ 08046 Phone: 609-835-2901 |
Keith A. Comber, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 218a Sunset Rd, Willingboro, NJ 08046 Phone: 609-835-2901 |
Ms. Lori Sleeper, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 218 Sunset Rd # A, Willingboro, NJ 08046 Phone: 609-835-3069 Fax: 856-829-0580 |
News Archive
The 2008 Joint Meeting of the American Academy of Ophthalmology (Academy) and European Society of Ophthalmology (SOE), the largest and most comprehensive ophthalmic educational meeting in the world, is in session November 8 to 11 at the Georgia World Congress Center, Atlanta.
Several genes that play a role in how our body's cells normally auto-destruct may play a role in age-related hearing loss, according to research published online in the journal Apoptosis - a journal devoted to the topic of cell suicide, or programmed cell death.
PharMEDium Healthcare Corporation has become an Industry Supporter of the American Society of Anesthesiologists, as a part of a new Corporate Supporter program available to pharmaceutical, medical device and practice management companies.
St. Jude Children's Research Hospital scientists have identified a protein that certain high-risk acute lymphoblastic leukemia (ALL) cells need to survive and have used that knowledge to fashion a more effective method of killing tumor cells. The findings appear in the August 29 edition of the journal Blood.
BioLight Life Sciences Investments, a company focused primarily on the discovery, development and commercialization of breakthrough ophthalmic diagnostics and therapeutics, announced today that it has entered into a joint financing agreement (the "Agreement") with two Asia-based venture capital firms (the "New Investors"), pursuant to which BioLight and the New Investors will make a direct equity investment in BioLight's IOPtima Ltd. subsidiary via a private placement.
› Verified 5 days ago